The Contracting Education Academy

Contracting Academy Logo
  • Home
  • Training & Education
  • Services
  • Contact Us
You are here: Home / Archives for research

December 14, 2020 By cs

IRS moves to speed up contracting through new procurement research partnership

The Internal Revenue Service recently set sights on introducing new technology-driven capabilities and applying innovative data science techniques to improve and elevate its procurement operations.

And last week, the agency launched a research partnership valued at almost $1 million that marks a deliberate move in that direction.

Through the newly unveiled collaboration, agency officials, university professors and students equipped with procurement and machine learning experience, and members of Virginia-based small business Data and Analytic Solutions will form a multidisciplinary team intended to accelerate the IRS’ contracting and award processes.  It emerges as federal buying largely remains notoriously slow.

“When it comes to contracting, everyone seems to want it faster, cheaper, and better,” IRS Chief Procurement Officer Shanna Webbers told Nextgov over email Tuesday.  “We recognized that we cannot continue to do business as usual and expect a different result.”

With that view top of mind, Webbers’ office earlier this year embarked on what she called “a game-changing transformation” that drew from feedback shared by procurement employees within the agency, as well as its customers and industry partners.  Building on that, the organization is bringing forth new tools and techniques — like data analysis, visualization, and machine learning, among others — to advance how work is performed.

Keep reading this article at: https://www.nextgov.com/emerging-tech/2020/12/irs-moves-speed-contracting-through-new-procurement-research-partnership/170431/

Filed Under: Government Contracting News Tagged With: acquisition reform, category management, data analytics, IRS, lead time, machine learning, modernization, PALT, procurement reform, research, streamlined acquisition process, visualization

September 28, 2020 By cs

DoD is not getting what it wants from subsidized industry research

R&D spending doesn’t match DoD’s priorities, report says.

Most of the $4 billion to $5 billion the Department of Defense (DoD) gives to corporations each year to subsidize their research is not used in ways that work toward the Pentagon’s goals, a report from the Government Accountability Office (GAO) found.

The study may be further ammo for DoD’s previous effort to have more control over the way corporations use their independent research and development (IRAD) money; something the companies have strongly fought against.

“DoD does not know how contractors’ IRAD projects fit into the department’s technology goals,” the authors of the report wrote. “As a result, DoD risks making decisions about its multi-billion dollar science and tech investments that could duplicate work or miss opportunities to fill in gaps that the contributions of private industry do not cover.”

In 2018, only 38% of corporations’ IRAD money went to the 10 topics DoD has outlined as its most important modernization priorities like cyber, artificial intelligence, microelectronics and biotechnology.

Corporations spent about 80% of their IRAD month on short-term investments intended to maintain near-term profitability, according to the report.  Only 20% went to long-range research investments meant to disrupt current technologies.  Those longer-term investments are the ones DoD has been telegraphing a need for since the middle of the Obama administration when the Pentagon shifted its focus to near-peer competitors like China and Russia.  One of the first big pushes for renewed radical innovation came from the Third Offset Strategy, headed by former Deputy Defense Secretary Bob Work, which sought to keep the United States technologically superior to its adversaries.

Keep reading this article at: https://federalnewsnetwork.com/dod-reporters-notebook-jared-serbu/2020/09/most-of-industrys-rd-spending-doesnt-match-dods-priorities-report-says/

Filed Under: Government Contracting News Tagged With: DoD, GAO, government spending, IRAD, R&D, research

September 16, 2020 By cs

Pentagon, Defense contractors are out of step on tech innovation, GAO finds

The Pentagon wanted to fund ambitious research into future tech breakthroughs but contractors spend most of their money on safer bets, GAO has found.

Two years after the Pentagon set out to spend billions on 10 breakthrough research and engineering efforts, defense contractors instead are putting most of their money in less ambitious research projects.

The development gap between the military and its suppliers troubled investigators at the Government Accountability Office, or GAO, who determined in a report released last Thursday that the Defense Department isn’t keeping good watch over those private efforts and doesn’t know how much of it would fit into the military’s tech goals.

The Pentagon’s undersecretary for research and engineering in 2018 laid out several big idea research areas that would be most relevant to maintaining an edge on China or Russia.  Many are in the very early stages of maturation; the biggest breakthroughs are expected in the second half of the coming decade.

Keep reading this article at: https://www.defenseone.com/technology/2020/09/pentagon-defense-contractors-are-out-step-tech-innovation-gao-finds/168237/

Filed Under: Government Contracting News Tagged With: Air Force, breakthrough, China, defense contractors, DoD, GAO, innovation, Pentagon, research, Russia

August 19, 2020 By cs

Georgia Tech to lead technology coalition to advance inclusive innovation across the state

Announced by Lt. Gov. Geoff Duncan on Aug. 17, Georgia Tech will take a lead role in the Partnership for Inclusive Innovation, a public-private partnership created to foster technology access, growth, entrepreneurship, and evolution across the state of Georgia. The organization is the first of its kind — a statewide, public-private partnership built from the ground up entirely in a virtual environment.

The new organization follows the foundational work of the Georgia Innovates Task Force, established by Lt. Gov. Duncan in January 2020. The task force, under the chairmanship of G.P. “Bud” Peterson, president emeritus of Georgia Tech, and former U.S. Senator Johnny Isakson, made recommendations last month to formalize efforts that will establish the state as a national leader in technology research, development, and implementation.  Peterson will continue as board chair.  Debra Lam, current managing director of Smart Cities and Inclusive Innovation at Georgia Tech, has been named executive director of the new organization.

“Through collaboration between industry and education, the Partnership for Inclusive Innovation has the potential to transform our entire state and the lives of its citizens,” said Ángel Cabrera, president, Georgia Tech. “ We are very grateful to Lt. Gov. Geoff Duncan for creating the Georgia Innovates Task Force earlier this year, and for the thousands of volunteer hours that my predecessor, co-chair G.P. “Bud” Peterson, and other civic and community leaders and supporting organizations invested in creating this exciting vision.  We at Georgia Tech are honored to help Georgia maximize inclusive innovation throughout our state.”

Following the recommendations of the task force and building on the state’s existing infrastructure and leadership, the organization’s focus will center on “foundational, transformational, and sustaining” work throughout the state of Georgia that is guided by principles of connectedness, talent, diversity, sustainability, and identity.  Pilot programs will focus on providing access to digital resources and education; advancing agriculture, food system innovation, venture capital growth, and lab-to-market tech transfer; and ensuring resources, access, and opportunities are sustained via public-private partnerships.

Advancement efforts will include a series of high-impact, low-cost pilot programs, including K-12 Digital Readiness, Advanced Food Supply Innovation, and Regional Industry/Education Collaboratives. The first set of pilots, including Civic Data Science for Equitable Development in Savannah and a Traffic Monitoring and Communication System in Valdosta, were recently announced by the Georgia Smart Communities Challenge.

Georgia Tech research across a broad range of disciplines, including optical technology, will help define Georgia’s identity as a national leader in technology research, development and implementation. (Credit: Christa Ernst, Georgia Tech)

“Georgia Tech’s leadership role in the Partnership for Inclusive Innovation is an ongoing testament to its strategic mission of advancing technology to improve the human condition,” said Lam. “The Partnership for Inclusive Innovation’s establishment also reflects the level and depth of statewide commitment to improve access and opportunities for all Georgians.  It was an honor to work with the full Georgia Innovates Task Force, and I look forward to working with the esteemed board of advisors and the greater innovation ecosystem to deliver real impact.”

Additional pilots are planned, with the Partnership for Inclusive Innovation working closely with local governments, startups, nonprofits, and other collaborators, increasing access to educational, entrepreneurial, and technological opportunities for Georgians as well as attracting new talent to the state’s workforce. Program funding will be provided through a combination of state, industry, and philanthropic support.

Joining Peterson and Lam, the board for the Partnership for Inclusive Innovation will include members representing government, industry, and higher education organizations.

Source: http://news.gatech.edu/2020/08/17/georgia-tech-lead-technology-coalition-advance-inclusive-innovation-across-state

Filed Under: Georgia Tech News Tagged With: diversity, entrepreneurship, Georgia Innovates Task Force, Georgia Tech, innovation, optical technology, Partnership for Inclusive Innovation, pilot, research, Smart Cities, sustainability, technology

May 28, 2020 By cs

Georgia Tech researchers receive NIH funds for adjuvant research to boost Coronavirus vaccines

Researchers have received funding from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to screen and evaluate certain molecules known as adjuvants that may improve the ability of coronavirus vaccines to stimulate the immune system and generate appropriate responses necessary to protect the general population against the virus.

“The adjuvants that we are studying, known as pathogen-associated molecular patterns (PAMPs), are molecules often found in viruses and bacteria, and can efficiently stimulate our immune system,” explained Krishnendu Roy, a professor and Robert A. Milton Chair in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. “Most viruses have several of these molecules in them, and we are trying to mimic that multi-adjuvant structure.”

Adjuvants are used with some vaccines to help them create stronger protective immune responses in persons receiving the vaccine. The research team will screen a library of various adjuvant combinations to quickly identify those that may be most useful to enhance the effects of both protein- and RNA-based coronavirus vaccines under development.

“We are trying to understand how adjuvant combinations affect the vaccine response,” Roy said. “We will look at how the immune system shifts and changes with the adjuvant combinations. The ultimate goal is to determine how to generate the most effective, strongest, and most durable immune response against the virus. There are more than a hundred vaccine candidates being developed for the SARS-CoV-2 virus, which causes COVID-19, and it is likely that many will generate initial antibody responses. It remains to be seen how long those responses will last and whether they can generate appropriate immunological memory that protects against subsequent virus exposures in the long-term.”

The parent grant to Georgia Tech is part of a program called “Molecular Mechanisms of Combination Adjuvants (MMCA).” For the past four years, the agency has been supporting Roy and his research team to pursue studies to understand how adjuvants work, and this additional funding will allow them to apply their research to potential coronavirus vaccines.

“It has been difficult to develop safe and durable vaccines against respiratory viruses,” explained Roy, who also directs the Center for ImmunoEngineering.  “Over the past several years, we have been looking mostly at the basic science and understanding how the immune system integrates signals from multiple adjuvants to create a unified immune response in mammals. This new funding will allow us to pursue more translational aspects related to COVID-19 and provide the scientific community with potentially new tools to fight this devastating pandemic.”

The team has developed a technique that uses micron- and nanometer-scale polymer particles to present both the vaccine antigen and adjuvant compounds to the mammalian immune system. The medical polymer that is the basis for the particles is used for other purposes in the body.

The synthetic particles, which Roy’s team calls pathogen-like particles (PLPs), are designed to mimic real pathogens in terms of how they elicit immune responses – without causing infection. “They have an antigen and multiple synergistic adjuvants on a particle-structure that is very similar to how native pathogens present these molecules to our immune system,” he said.

The PLPs combined with adjuvants encourage the immune system to develop antibodies and T cell responses that can battle the real pathogen if it attacks. Having existing antibodies and the appropriate virus-fighting T cells to the novel coronavirus will enable the body’s immune system to respond quickly to the threat of infection and potentially destroy the virus quickly.

The researchers will first evaluate how the adjuvants affect the interaction of specific immune cells, called dendritic cells and macrophages, with T cells – a key component of generating immune system response – and then follow up with animal studies using the promising combinations. Whether or not a vaccine can be created that will provide long-term protective immunity against the coronavirus is still an open question in the research community, and Roy said the research into adjuvants will help provide new tools to answer that question.

Krishnendu Roy, a professor and Robert A. Milton Chair in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, and his research team has received NIH funding to screen and evaluate certain molecules known as adjuvants that may improve the ability of coronavirus vaccines to stimulate the immune system. (Photo: Rob Felt, Georgia Tech)

“Part of the knowledge gap right now is that we don’t know how the immune system is influenced by various adjuvants,” he said. “We need to look at how the vaccine formulations, our particles and the adjuvants affect T cell proliferation and T cell response, and how we can optimize that response to generate durable immunity.”

The adjuvant Alum has been used since the 1930s to boost the action of the immune system as it responds to antigens in vaccines that elicit protection against many pathogens. However, for those pathogens that require alternative adjuvants, only a few other adjuvants are currently used in commercial vaccines. Research on modern adjuvants aims to understand the way they specifically activate our immune systems and can be designed to protect against infections. Another approach is to find out if combinations of adjuvants are safe and more effective than a single adjuvant providing highly effective and long-lasting protective immunity.

Roy and his team will be evaluating existing adjuvants in combination, along with potential protein and RNA-based antigens currently under evaluation. The goal is to develop novel combinations of current adjuvants, including adjuvants approved for use and others that are still in development. “In this work, the strategy is to take existing platforms and see how we can pivot them to understand how to make the COVID vaccines better, and do it rapidly.”

As with other research into potential coronavirus vaccines, the work is being accelerated with the goal of creating a safe and effective vaccine against the pandemic virus as soon as possible.

“There are multiple efforts that the NIH and others are funding to really accelerate the pace of the work to see how many different approaches we can come up with and to evaluate the differences,” Roy said. “The goal is to determine what data we can generate very quickly to move toward a successful vaccine that is safe, durable, affordable, scalable, and effective. Evaluating different approaches will help increase the likelihood that we’ll find one or more that meet these criteria.”

Source: http://www.news.gatech.edu/2020/05/20/researchers-receive-nih-funds-adjuvant-research-boost-coronavirus-vaccines


This research is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under supplemental funding to award number U01AI124270. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


For more coverage of Georgia Tech’s response to the coronavirus pandemic, please visit our Responding to COVID-19 page.

Filed Under: Georgia Tech News Tagged With: coronavirus, COVID-19, Georgia Tech, NIH, pandemic, research

  • 1
  • 2
  • 3
  • …
  • 11
  • Next Page »

Popular Topics

abuse acquisition reform acquisition strategy acquisition training acquisition workforce Air Force Army AT&L bid protest budget budget cuts competition cybersecurity DAU DFARS DHS DoD DOJ FAR fraud GAO Georgia Tech GSA GSA Schedule GSA Schedules IG industrial base information technology innovation IT Justice Dept. Navy NDAA OFPP OMB OTA Pentagon procurement reform protest SBA sequestration small business spending technology VA
Contracting Academy Logo
75 Fifth Street, NW, Suite 300
Atlanta, GA 30308
info@ContractingAcademy.gatech.edu
Phone: 404-894-6109
Fax: 404-410-6885

RSS Twitter

Search this Website

Copyright © 2023 · Georgia Tech - Enterprise Innovation Institute